STAYBLE THERAPEUTICS
Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain triggered by degenerative changes in the disc. Stayble’s treatment has the potential to offer a solution that may alleviate or abolish the pain without the need for surgery Behind Stayble Therapeutics stands an experienced, multidisciplinary team including a world-renowned back-pain researcher, experienced bio-entrepreneurs and former big pharma senior management. Their vision is that this treatment concept will reach out to millions of patients who are disabled by chronic back pain. We believe this drug has the potential to drastically reduce the suffering from a widespread, incapacitating condition.
STAYBLE THERAPEUTICS
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2012-01-01
Address:
Göteborg, Vastra Gotaland, Sweden
Country:
Sweden
Website Url:
http://www.staybletherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+46 730 808 397
Email Addresses:
[email protected]
Total Funding:
5.06 M USD
Technology used in webpage:
CrUX Top 50m CrUX Dataset One.com DNS
Similar Organizations
Cellestia
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Ventaleon
Ventaleon is developing inhaled treatments against viral infections.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Chalmers Ventures AB
Chalmers Ventures AB investment in Post-IPO Equity - Stayble Therapeutics
Chalmers Ventures AB
Chalmers Ventures AB investment in Venture Round - Stayble Therapeutics
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Stayble Therapeutics
Chalmers Ventures AB
Chalmers Ventures AB investment in Venture Round - Stayble Therapeutics
Almi Invest
Almi Invest investment in Venture Round - Stayble Therapeutics
Chalmers Ventures AB
Chalmers Ventures AB investment in Venture Round - Stayble Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2024-07-23 | Stayble Therapeutics appoints new CFO |
Official Site Inspections
http://www.staybletherapeutics.com Semrush global rank: 4.84 M Semrush visits lastest month: 1.8 K
- Host name: moreya.oderland.com
- IP address: 91.201.60.165
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Stayble Therapeutics"
ANNUAL REPORT 2019 - staybletherapeutics.com
Finance and Organization Stayble’s headquarter is located in Gothenburg, Sweden. Two …See details»
Stayble Therapeutics | About Stayble - Stayble Therapeutics
Stayble Therapeutics’ treatment against herniated discs (LDH) has the potential to offer an …See details»
Stayble Therapeutics - Crunchbase Company Profile & Funding
Stayble Therapeutics is developing a minimally invasive injection-based treatment against …See details»
Stayble Therapeutics - LinkedIn
Stayble is a clinical stage pharmaceutical company developing the injectable treatment …See details»
Stayble Therapeutics AB, STABL:STO profile - FT.com
Nov 8, 2024 Stayble Therapeutics AB (STABL:STO) company profile with history, revenue, …See details»
Stayble Therapeutics AB, 4K4:STU profile - FT.com - Financial Times
5 days ago Stayble Therapeutics AB (4K4:STU) company profile with history, revenue, …See details»
Stayble Therapeutics - Company Profile - Tracxn
5 days ago Stayble Therapeutics is developing a novel treatment for chronic low back pain …See details»
Board of Directors - Stayble Therapeutics
Board member since 2021 GUDRUN ANSTRÉN, born 1955. Gudrun is a trained pharmacist …See details»
Stayble Therapeutics - Overview, News & Similar companies
Apr 15, 2024 (SV) Kallelse till årsstämma i Stayble Therapeutics AB Aktieägarna i Stayble …See details»
Stayble Therapeutics Company Profile 2024: Stock ... - PitchBook
Stayble Therapeutics General Information Description. Stayble Therapeutics AB is a clinical …See details»
Stayble Therapeutics - Products, Competitors, Financials, …
Mar 9, 2020 staybletherapeutics.com. Overview & Products; Financials; Founded Year 2012. …See details»
Stayble Therapeutics - VentureRadar
Similar Companies: Sun BioPharma USA Privately Held Sun BioPharma is developing small …See details»
Stayble Therapeutics - Chalmers Ventures
Stayble Therapeutics is a clinical-stage company developing a truly innovative, non-surgical …See details»
Overview - Stayble Therapeutics
Stayble Therapeutics is a clinical pharmaceutical company developing an injection-based …See details»
STABL: Stayble Therapeutics AB Stock Price Quote - Bloomberg
Nov 15, 2024 Stock analysis for Stayble Therapeutics AB (STABL:FN Stockholm) including …See details»
Staybe Therapeutics sees optimism amongst study clinics
2 July, 2021During 2020, Stayble Therapeutics, despite the Covid-19-pandemic, managed to …See details»
Financial Reports - Stayble Therapeutics
M. Sc, CEO. Andreas Gerward. Andreas has during the last 10 years worked with …See details»
STABL Stock Price Quote | Morningstar
Nov 15, 2024 See the latest Stayble Therapeutics AB Ordinary Shares stock price …See details»
Press releases - Stayble Therapeutics
M. Sc, CEO. Andreas Gerward. Andreas has during the last 10 years worked with …See details»